Cardurion Pharmaceuticals, Inc.
Clinical trials sponsored by Cardurion Pharmaceuticals, Inc., explained in plain language.
-
Can a new pill help a failing heart pump better?
Disease control Recruiting nowThis clinical trial is testing an experimental drug called CRD-4730 in people with heart failure with reduced ejection fraction (HFrEF), a condition where the heart's main pumping chamber is weak. The drug works by blocking a protein called CaMKII, which is thought to contribute …
Phase: PHASE2 • Sponsor: Cardurion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New drug aims to tame rare, Exercise-Triggered heart condition
Disease control Recruiting nowThis study tests an experimental drug called CRD-4730 in 12 adults with a rare inherited heart condition (CPVT) that can cause dangerous heart rhythms during exercise or stress. Participants will receive two different doses of the drug and a placebo in random order to see if it s…
Phase: PHASE2 • Sponsor: Cardurion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC